Evaluation Of Functional Analogs Of CC-1065 And The Duocarmycins ...
Có thể bạn quan tâm
The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation- Clipboard
- My Bibliography
- Collections
- Citation manager
Save citation to file
Format: Summary (text) PubMed PMID Abstract (text) CSV Create file CancelEmail citation
Email address has not been verified. Go to My NCBI account settings to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email CancelAdd to Collections
- Create a new collection
- Add to an existing collection
Add to My Bibliography
- My Bibliography
Your saved search
Name of saved search: Search terms: Test search terms Would you like email updates of new search results? Saved Search Alert Radio Buttons- Yes
- No
Create a file for external citation management software
Create file CancelYour RSS Feed
Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link CopyFull text links
Elsevier Science Full text links Actions
CiteCollectionsAdd to Collections- Create a new collection
- Add to an existing collection
Page navigation
- Title & authors
- Abstract
- Publication types
- MeSH terms
- Substances
- Grants and funding
- LinkOut - more resources
Abstract
The DNA alkylation properties and in vitro cytotoxic activity of a series of analogs of CC-1065 and the duocarmycins incorporating the 9a-chloromethyl-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-one (C2BI) alkylation subunit are detailed. The C2BI-based agents have been shown to alkylate DNA within the minor groove in a fashion analogous to CC-1065 or duocarmycin. The stereoelectronically-controlled adenine N3 addition to the least substituted cyclopropane carbon occurs with a selectivity that represents a composite of the two enantiomers of the corresponding CBI-based agents. Additional high affinity alkylation sites were detected which were not prominent alkylation sites for either enantiomer of the CBI-based agents. Such sites may represent induced high affinity alkylation sites resulting from DNA cross-linking following complementary strand alkylation at a high affinity alkylation site and each such site detected proved consistent with predicted models of an adenine-adenine cross-linking event. Further, consistent with this interpretation, the C2BI agents were shown to constitute efficient cross-linking agents with DNA cross-linking being observed at the same concentrations as DNA alkylation. In comparison to the parent CBI-based agents, the C2BI-based agents proved to be approximately 100-10,000x less effective at DNA alkylation and 100-10,000x less potent in cytotoxic assays. This is suggested to be the consequence of a significant steric deceleration of the adenine N3 alkylation reaction attributable to the additional 9a-chloromethyl substituent. Consistent with this interpretation, the noncovalent binding constant of C2BI-CDPI2 for poly[dA]-poly[dA]-poly[dT] proved nearly identical to that of CDPI3 under kinetic binding conditions, and prolonged incubation of C2BI-CDPI2 with poly[dA]-poly[dT] (72 h, 25 degrees C) provided covalent complexes with a helix stabilization comparable to that observed with (+)- or (-)-CPI-CDPI2 indicating that the size of the C2BI subunit inhibits but does not preclude productive DNA alkylation.
PubMed Disclaimer
Publication types
- Research Support, U.S. Gov't, P.H.S. Actions
- Search in PubMed
- Search in MeSH
- Add to Search
MeSH terms
- Alkylation Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Antibiotics, Antineoplastic / chemistry* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Antibiotics, Antineoplastic / toxicity Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Base Composition Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Base Sequence Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Binding Sites Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Cross-Linking Reagents Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- DNA / chemistry Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Duocarmycins Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Electrophoresis, Polyacrylamide Gel Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Indoles* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Leucomycins / chemistry* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Leucomycins / toxicity Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Magnetic Resonance Spectroscopy Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Molecular Sequence Data Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Nucleic Acid Denaturation Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Pyrrolidinones / chemistry Actions
- Search in PubMed
- Search in MeSH
- Add to Search
Substances
- 9a-chloromethyl-1,2,9,9a-tetrahydrocyclopropa(c)benz(e)indol-4-one Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Antibiotics, Antineoplastic Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Cross-Linking Reagents Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Duocarmycins Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Indoles Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Leucomycins Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Pyrrolidinones Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- CC 1065 Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- DNA Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- duocarmycin A Actions
- Search in PubMed
- Search in MeSH
- Add to Search
Grants and funding
- CA41986/CA/NCI NIH HHS/United States
- CA55276/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database
Elsevier Science [x] Cite Copy Download .nbib .nbib Format: AMA APA MLA NLM Send To - Clipboard
- Save
- My Bibliography
- Collections
- Citation Manager
NCBI Literature Resources
MeSH PMC Bookshelf Disclaimer
The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.
Từ khóa » C2bi
-
C2bi – Ingénierie De La Construction
-
C2BI Ingenierie - Crunchbase Company Profile & Funding
-
C2BI Ingenierie - Crunchbase
-
C2bi | LinkedIn
-
C2BI | LinkedIn
-
C2BI | Facebook
-
C2BI - Home | Facebook
-
C2Bi - Archello
-
C2Bi - ArchDaily
-
C2BI LTD Overview - Find And Update Company Information - GOV.UK
-
C2BI Ingenierie Information - RocketReach
-
APM Unmanage Report-.c2Bi - Forum - Network Performance ...
-
C2bi - Overview, News & Competitors
-
C2bi Overview | SignalHire Company Profile